Vita means life. It's also our platform for sharing the stories of biotech's promise to patients and public health.
CSL consists of CSL Behring, CSL Seqirus and CSL Vifor. Learn more by visiting each section.
Biotechnology leader CSL Behring offers the broadest range of quality plasma-derived and recombinant therapies in our industry.
Derived from the expression 'securing health for all of us', CSL Seqirus is one of the world's largest influenza vaccine providers.
R&D focuses its expertise on four strategic platforms: plasma protein technology; recombinant technology; cell and gene therapy; and vaccines technology.
One of our core values at CSL is Innovation. We support collaborative innovation through the endowment of awards and grants to researchers around the world.
As part of our broader sustainability strategy to build a more sustainable future, CSL commits to reduce absolute Scope 1 and 2 greenhouse gas emissions by 42% by FY2030.
Along with our sustainability strategy, CSL’s community contribution framework helps deliver on our Values and support execution of our 2030 strategy.
At CSL, Inclusion and Belonging is at the core of our mission and who we are. It fuels our innovation day in and day out.
Whether you are early in your college education or recently completed your degree, it's never too soon to consider CSL for your Promising Future!
Test your knowledge of hereditary angioedema, a rare disease that causes unpredictable swelling.
Medical innovation has soared, but a new coalition says more coordination and collaboration are needed to speed progress for …
Your medical journey is uniquely your own. Are you ready to share your story? Get started with this writing exercise from Pul…
CSL Behring’s Policy, Advocacy and Government Affairs team recently met with a panel of leaders who represent caregivers in t…
Hear from one of the minds behind CSL Seqirus’ long-term strategy.
Medical training should evolve with the times, both students and practicing doctors say. Will the next generation of doctors …
In honor of Rare Disease Day later this month, new podcast episode welcomes a special guest to discuss the importance of ment…
February 28 is Rare Disease Day. How much do you know about the global impact of rare conditions?
CSL Behring, which makes medicines for rare and serious diseases, recently met with medicine distributors representing 20 cou…
Americas
Asia Pacific
Middle East
Europe
